Phase 3 Acute Myeloid Leukaemia Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 2Phase 3
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
Acute Myeloid Leukaemia (AML)
Moleculin Biotech, Inc.312 enrolled25 locationsNCT06788756
Not Yet Recruiting
Phase 3
ALLG AMLM29 CAVIAT-R (Chemotherapy and Venetoclax in Acute Myeloid Leukaemia (AML) Trial- Randomised): a multicentre phase III trial investigating venetoclax plus intensive chemotherapy for newly diagnosed AML
Acute Myeloid Leukaemia
Australasian Leukaemia and Lymphoma Group390 enrolled1 locationACTRN12625001003460
Recruiting
Phase 3
MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
Acute Myeloid Leukaemia
Zhongnan Hospital154 enrolled11 locationsNCT06345365
Recruiting
Phase 3
International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia
Acute Myeloid Leukaemia
University of Birmingham700 enrolled68 locationsNCT02724163
Completed
Phase 3
Phase III Clinical Study of Allogeneic Stem Cell Transplantation with Reduced Conditioning (RICT) versus Best Standard of Care in Acute Myeloid Leukemia (AML) in First Complete Remission
Acute Myeloid Leukaemia
Australasian Leukaemia & Lymphoma Group (ALLG)40 enrolled3 locationsACTRN12614000351617